Inflammatory cytokine gene expression pathway

Inflammatory cytokine gene expression pathways are the coordinated intracellular signaling networks responsible for the transcriptional activation of genes encoding pro-inflammatory mediators. These pathways, most notably the Nuclear Factor-kappa B (NF-κB), Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT), and Mitogen-Activated Protein Kinase (MAPK) cascades, are typically initiated by the activation of cell-surface receptors like Toll-like receptors (TLRs) or cytokine receptors [Oeckinghaus & Ghosh, 2009; Hu et al., 2021]. Upon activation, signal transduction leads to the nuclear translocation of transcription factors that bind to specific DNA sequences, driving the production of cytokines such as TNF, IL-1, and IL-6. While essential for host defense and wound healing, chronic or excessive activation of these pathways is a hallmark of numerous pathologies, including rheumatoid arthritis, inflammatory bowel disease, and cytokine release syndrome [Liu et al., 2017]. Pharmacological modulation of these pathways aims to restore immune homeostasis by selectively blocking key enzymatic or transcriptional nodes, thereby reducing the systemic inflammatory burden [FDA, 2021]. For instance, JAK inhibitors prevent the phosphorylation of STAT proteins, while glucocorticoids act through the glucocorticoid receptor to repress the activity of NF-κB and other pro-inflammatory transcription factors [StatPearls, 2023]. These interventions are highly effective but carry risks of systemic immunosuppression and opportunistic infections due to the broad role of these pathways in normal immune function.

Other names

Pro-inflammatory signaling pathwaysCytokine signaling cascadesInflammatory gene regulationCytokine induction pathways

Inhibition of intracellular signaling components such as Janus kinases (JAKs) to prevent STAT phosphorylation and subsequent nuclear translocation, or modulation of nuclear receptors (e.g., glucocorticoid receptor) to antagonize NF-κB and AP-1 mediated transcription [StatPearls, 2023; Liu et al., 2017].